Clinic
Eastern Carolina Medical Center, PC
Eastern Carolina Medical Center, PC was paid $1.50M by Medicaid between Jan 2018 and Dec 2024, across 107 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoEASTERN CAROLINA MEDICAL CENTER, PC
BENSON, NC 27504
BENSON, NC 27504
33aNPI1609822287assigned 05/26/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$1.50M
24GClaims214,945
24DCodes billed107
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in North Carolina
Rank by total paid#16 of 69
Median peer was paid$333K
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,001 | $166K | |
| 2019 | 12,943 | $176K | |
| 2020 | 16,544 | $167K | |
| 2021 | 33,854 | $254K | |
| 2022 | 42,805 | $286K | |
| 2023 | 44,392 | $238K | |
| 2024incomplete | 49,406 | $212K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 13,907 | 9,900 | $429K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 9,330 | 6,944 | $196K |
| 99199 | Unlisted special service, procedure or report | 9.8% | 32,024 | 20,735 | $147K |
| 99490 | Ccm add 20min | 8.0% | 11,787 | 10,023 | $120K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4.9% | 1,365 | 990 | $74K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.2% | 6,564 | 4,712 | $63K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 974 | 611 | $39K |
| 80061 | Lipid panel | 2.5% | 7,814 | 5,597 | $38K |
| 93880 | 2.5% | 893 | 624 | $38K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 6,748 | 4,856 | $33K |
| 99454 | 1.9% | 1,530 | 1,079 | $29K | |
| 80053 | Comprehensive metabolic panel | 1.7% | 9,410 | 6,863 | $26K |
95 more codes
| 99457 | 1.7% | 1,560 | $25K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.7% | 7,789 | $25K |
| 82607 | 1.6% | 5,513 | $24K | |
| 84439 | 1.3% | 6,802 | $20K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 8,192 | $19K |
| 99439 | <1% | 1,348 | $15K | |
| 99458 | <1% | 806 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,507 | $11K |
| 93923 | <1% | 437 | $11K | |
| 99497 | <1% | 1,554 | $10K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 180 | $7K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 329 | $7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 73 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,195 | $6K |
| 90739 | <1% | 312 | $6K | |
| 90682 | <1% | 297 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,398 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 445 | $3K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 92 | $3K |
| 77080 | <1% | 273 | $3K | |
| 94060 | <1% | 246 | $3K | |
| 93000 | <1% | 573 | $3K | |
| 93925 | <1% | 26 | $2K | |
| 82746 | <1% | 537 | $2K | |
| 95923 | <1% | 155 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 92 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 167 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 220 | $2K |
| 82728 | <1% | 887 | $2K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 368 | $2K |
| 94729 | <1% | 244 | $2K | |
| 95921 | <1% | 128 | $1K | |
| 99305 | <1% | 26 | $1K | |
| 94727 | <1% | 244 | $1K | |
| 83550 | <1% | 874 | $1K | |
| 99408 | <1% | 165 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 136 | $986.20 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 46 | $909.78 |
| 83540 | <1% | 878 | $816.21 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 45 | $732.15 |
| 99406 | <1% | 400 | $703.36 | |
| 85046 | <1% | 895 | $671.99 | |
| 82043 | <1% | 464 | $609.12 | |
| 71271 | <1% | 18 | $572.90 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 321 | $541.82 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 54 | $525.48 |
| 82570 | <1% | 436 | $516.02 | |
| 99325 | <1% | 19 | $514.54 | |
| 93015 | <1% | 61 | $509.14 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 16 | $503.15 |
| 96127 | <1% | 166 | $450.38 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $435.78 |
| 81001 | <1% | 292 | $419.56 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 19 | $410.48 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 46 | $410.04 |
| 90662 | <1% | 322 | $393.92 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 32 | $389.04 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 60 | $368.68 |
| 99223 | Prolong inpt eval add15 m | <1% | 13 | $260.58 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 1,390 | $240.30 |
| 80050 | General health panel | <1% | 26 | $170.77 |
| 81025 | <1% | 30 | $163.80 | |
| 3044F | <1% | 2,349 | $161.06 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 5,375 | $155.74 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 215 | $152.64 |
| 99397 | <1% | 55 | $131.18 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 64 | $125.84 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $116.00 |
| 83735 | <1% | 17 | $107.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $68.26 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 14 | $44.90 |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 790 | $34.09 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 155 | $29.32 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 19 | $27.85 |
| G0008 | Administration of influenza virus vaccine | <1% | 658 | $17.74 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 308 | $6.90 |
| 84550 | <1% | 13 | $5.57 | |
| 3079F | <1% | 3,847 | $1.42 | |
| 3075F | <1% | 3,097 | $1.22 | |
| 3074F | <1% | 6,606 | $0.46 | |
| 3078F | <1% | 6,965 | $0.32 | |
| 3077F | <1% | 693 | $0.06 | |
| 1160F | <1% | 4,458 | $0.01 | |
| 3080F | <1% | 21 | $0.01 | |
| 1159F | 0% | 4,458 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 1,119 | $0.00 |
| 3062F | 0% | 71 | $0.00 | |
| 3288F | 0% | 15 | $0.00 | |
| 87999 | 0% | 37 | $0.00 | |
| 3061F | 0% | 22 | $0.00 | |
| 3008F | 0% | 2,539 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 1,072 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 33 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 0% | 216 | $0.00 |
| 1170F | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVYAS, PANKAJ (OWNER & PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Eastern Carolina Medical Center | Benson, NC | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.